PCM
AMAG

Penserra Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Penserra Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-294
Closed -$2K – 1164
2020
Q3 		$2K Buy
+294
New +$2.79K ﹤0.01% 917

Penserra Capital Management's AMAG Position: Q4 2020 in Review

Penserra Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 294 shares — an estimated $2K sold.

Penserra Capital Management first reported a position in AMAG in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Penserra Capital Management reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Penserra Capital Management sold 294 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Penserra Capital Management first reported a position in AMAG Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Penserra Capital Management's AMAG Pharmaceuticals position peaked at $2K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.